SPK SPK Acquisition Corp
SPK Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on operating businesses in the telecommunications, media, and technology sectors in Asia. The company was incorporated in 2020 and is based in Shanghai, China.
On 2/14/2022 the company announced a proposed merger with Varian Biopharmaceuticals, Inc. (“Varian Bio”), a private, precision oncology company developing novel therapeutics for the treatment of cancer.
$10.30 +0.05 (0.49%)
As of 12/29/2022 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: Common stocks
Category3: Unknown
GICS sector: Financials
Industry: Shell Companies
Index country: USA
Country of incorporation:
IPO date: 07/23/2021
Outstanding shares: 6,596,275
Average volume: 33,515
Market cap: $0
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Quarterly filings: 10-Q
Annual filings: 10-K
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%